With the increasing demand for precision medicine in cancer patients, radiogenomics
emerges as a promising frontier. Radiogenomics is originally defined as a methodology for …

New spatial molecular technologies are poised to transform our understanding and
treatment of urological cancers. By mapping the spatial molecular architecture of tumours …

Background There is a growing interest on the association of radiomic features with genomic
signatures in oncology. Using computational methods, quantitative radiomic data are …

Despite advancements, prostate cancers (PCa) are a significant global health due to
delayed diagnosis and therapeutic resistance. This review delves into the complex …

Introduction The use of systematic biopsies in addition to targeted biopsies is based on
multiple studies showing that 15–20% of “clinically significant” cancers are missed on …

The present study investigated ultrasound (US) phenotypes reflecting prostate cancer (PCa)‐
related genetic mutations. Herein, integration of radiotranscriptomic data, US and contrast …

Simple Summary Radiomics is the extraction of high-dimensional quantitative features from
medical images. These features have shown potential to provide diagnostic and prognostic …

PROSPECTIVE randomized trials have demonstrated that targeted biopsy is superior to
systematic biopsy with respect to the diagnosis of grade group (GG) 2 or higher prostate …

Radiomic analysis, which has developed rapidly in recent years, has become extremely
popular as a promising subject for the future. Radiomic data obtained from prostate-specific …

Prostate cancer (PCa) is a common cancer among male patients worldwide. There has been
an urgent demand for efficiently identifying aggressive tumors to provide accurate diagnosis …